Rodriguez Arrieta, L.A. et al. (2025) “When skin reactions interrupt bone therapy: severe cutaneous adverse reaction to romosozumab leading to treatment discontinuation”, European Journal of Case Reports in Internal Medicine, 12(9). doi:10.12890/2025_05719.